wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35671356-7584DE84-5782-469B-8EBD-5021A9A38B2B
Q35671356-7584DE84-5782-469B-8EBD-5021A9A38B2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35671356-7584DE84-5782-469B-8EBD-5021A9A38B2B
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
P2860
Q35671356-7584DE84-5782-469B-8EBD-5021A9A38B2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35671356-7584DE84-5782-469B-8EBD-5021A9A38B2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e2969095f8864f1e39c2bdf207cc17d6ff0f7f4
P2860
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.